An act relating to miscellaneous provisions affecting the Department of Vermont Health Access

S.162 eliminates the Department of Vermont Health Access' (DVHA) annual requirement to create and publish lists of prescription drugs with significant price increases (over 50% in 5 years or 15% in a year). This directly affects DVHA, removing its duty to share these lists with the Green Mountain Care Board and Attorney General's office. The bill also modifies Medicaid Advisory Committee membership rules (barring reappointments), updates health insurance market language, adjusts Clinical Utilization Review Board composition, and increases burial funds exclusion for Medicaid eligibility. Other minor changes include extending the timeline for Medicaid doula service coverage approval.